Call Us08045479576
Iron Sucrose Powder

Iron Sucrose Powder

2000.0 INR/Kilograms

Product Details:

  • Heavy Metal (%) 20 ppm (parts per million)
  • Storage Room Temperature
  • Solubility Iron Sucrose Solubility Water: Highly soluble (forms a stable aqueous solution) Alcohol & Organic Solvents: Insoluble (does not dissolve in ethanol, chloroform, or ether) Physiological Solutions: Soluble in 0.9% sodium chloride (normal saline), which is commonly used for IV dilution.
  • Ph Level The pH level of Iron Sucrose solution typically ranges between 10.5 and 11.1.
  • Smell Other
  • HS Code 29420090
  • Particle Size nanometer range (~1-10 nm)
  • Click to View more
X

Iron Sucrose Powder Price And Quantity

  • 25 Kilograms
  • 2000.0 INR/Kilograms

Iron Sucrose Powder Product Specifications

  • Room Temperature
  • dark brown, aqueous solution
  • 20 ppm (parts per million)
  • Iron(III)-hydroxide sucrose complex
  • Iron Sucrose Solubility Water: Highly soluble (forms a stable aqueous solution) Alcohol & Organic Solvents: Insoluble (does not dissolve in ethanol, chloroform, or ether) Physiological Solutions: Soluble in 0.9% sodium chloride (normal saline), which is commonly used for IV dilution.
  • Medicine Grade
  • The pH level of Iron Sucrose solution typically ranges between 10.5 and 11.1.
  • Other
  • Iron Sucrose Usage Iron sucrose is primarily used for treating iron deficiency anemia (IDA), especially in patients with chronic kidney disease (CKD). It is given as an intravenous (IV) infusion or slow IV injection in a medical setting. Indications: Iron Deficiency Anemia (IDA) in CKD Patients Non-dialysis CKD patients who cannot tolerate or do not respond to oral iron. Hemodialysis patients receiving erythropoietin therapy. Peritoneal dialysis patients with iron deficiency. Patients Who Cannot Tolerate Oral Iron Those with gastrointestinal disorders (e.g., inflammatory bowel disease). Patients experiencing severe side effects from oral iron (nausea, constipation). Post-Surgical or Severe Blood Loss Cases Used to rapidly restore iron levels in cases of acute blood loss. Iron Deficiency in Pregnant Women (in certain cases, under medical supervision) Administration: Given intravenously as a slow injection or infusion. Dosage varies based on iron deficiency severity and patient condition.
  • 29420090
  • nanometer range (~1-10 nm)
  • C H Fe O
  • Venofer (iron sucrose)
  • 3 Years
  • C12H29Fe5Na2O23
  • Sweet
  • 8047-67-4.
  • 95% to 98%.
  • loss on drying is generally less than 5%
  • 618-670-3
  • Other
  • 864.64 Grams (g)
  • Iron sucrose does not have a well-defined melting point because it is a complex colloidal solution rather than a pure crystalline substance.
  • 766.4 C
  • Liquid

Iron Sucrose Powder Trade Information

  • INDIA
  • Letter of Credit at Sight (Sight L/C) Cash Advance (CA) Cash in Advance (CID) Days after Acceptance (DA) Letter of Credit (L/C)
  • 100 Kilograms Per Day
  • 7 Days
  • Yes
  • Free samples are available
  • Drum/Bag packing
  • Asia North America South America Eastern Europe Western Europe Australia Central America Middle East Africa
  • All India
  • WE PROVIDES ALL KIND OF CERTIFICATIONS AS YOU REQUIRED

Product Description

Iron Sucrose Description

Iron sucrose is an intravenous iron replacement therapy used to treat iron deficiency anemia, particularly in patients with chronic kidney disease (CKD). It consists of a complex of polynuclear iron (III) hydroxide with sucrose, which helps improve iron absorption and utilization.

Chemical & Physical Properties:

  • Chemical Formula: CHFeO (approximate structure)
  • Molecular Weight: Varies due to complex nature
  • Appearance: Dark brown, aqueous solution for injection
  • Solubility: Water-soluble

Mechanism of Action:

Iron sucrose releases bioavailable iron, which binds to transferrin in the bloodstream. Transferrin transports iron to the bone marrow, where it is used for red blood cell (RBC) production, improving hemoglobin levels.

Pharmacokinetics:

  • Absorption: Rapidly enters plasma after IV administration
  • Distribution: Binds to transferrin and is taken up by the reticuloendothelial system (RES)
  • Elimination: Iron is incorporated into hemoglobin or stored as ferritin; excess iron is excreted minimally

Uses & Indications:

  • Treatment of iron deficiency anemia in CKD patients
  • Patients on dialysis, especially those receiving erythropoietin therapy
  • Iron deficiency in patients who cannot tolerate or do not respond to oral iron

    Key Details:

    • Brand Names: Venofer, among others.
    • Administration: Given as an IV infusion or slow IV injection, typically in a healthcare setting.
    • Indications:
      • Iron deficiency anemia in CKD patients
      • Patients undergoing dialysis or erythropoietin therapy
      • Cases where oral iron is ineffective or causes side effects

    Dosage & Administration:

    • Administered based on iron levels and individual needs.
    • Typically given in multiple doses over several sessions.
    • Requires monitoring to avoid iron overload.

    Side Effects:

    • Common: Nausea, dizziness, low blood pressure, headaches.
    • Serious: Allergic reactions (rare but possible), anaphylaxis, hypotension.

    Precautions:

    • Should be given under medical supervision.
    • Avoid in patients with iron overload disorders like hemochromatosis.
    • Monitor hemoglobin and ferritin levels regularly.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category